Hollencrest Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Sell
4,993
-10,211
-67% -$2.38M 0.08% 136
2026
Q1
$3.72M Buy
15,204
+8,921
+142% +$2.08M 0.14% 78
2025
Q4
$1.3M Sell
6,283
-100
-2% -$19.8K 0.04% 133
2025
Q3
$1.18M Buy
6,383
+1
+0% +$171 0.04% 140
2025
Q2
$975K Sell
6,382
-692
-10% -$106K 0.04% 143
2025
Q1
$1.17M Sell
7,074
-50
-0.7% -$7.82K 0.05% 135
2024
Q4
$1.03M Sell
7,124
-139
-2% -$21.5K 0.04% 146
2024
Q3
$1.18M Sell
7,263
-145
-2% -$23.1K 0.05% 138
2024
Q2
$1.08M Sell
7,408
-2,839
-28% -$422K 0.05% 140
2024
Q1
$1.62M Sell
10,247
-251
-2% -$40K 0.07% 100
2023
Q4
$1.65M Sell
10,498
-2,266
-18% -$347K 0.16% 80
2023
Q3
$1.99M Sell
12,764
-538
-4% -$88.8K 0.23% 70
2023
Q2
$2.2M Sell
13,302
-813
-6% -$131K 0.23% 67
2023
Q1
$2.19M Buy
14,115
+1,973
+16% +$319K 0.23% 64
2022
Q4
$2.14M Buy
12,142
+80
+0.7% +$13.8K 0.27% 60
2022
Q3
$1.97M Sell
12,062
-144
-1% -$24.4K 0.25% 57
2022
Q2
$2.17M Sell
12,206
-199
-2% -$35.5K 0.25% 56
2022
Q1
$2.2M Sell
12,405
-15
-0.1% -$2.55K 0.2% 67
2021
Q4
$2.12M Buy
12,420
+65
+0.5% +$10.6K 0.17% 74
2021
Q3
$2M Buy
12,355
+2,267
+22% +$387K 0.18% 71
2021
Q2
$1.66M Sell
10,088
-2,558
-20% -$423K 0.15% 80
2021
Q1
$2.08M Buy
12,646
+1,496
+13% +$242K 0.2% 78
2020
Q4
$1.75M Buy
11,150
+150
+1% +$22.1K 0.18% 78
2020
Q3
$1.64M Sell
11,000
-15
-0.1% -$2.22K 0.2% 73
2020
Q2
$1.55M Buy
11,015
+648
+6% +$94.4K 0.21% 72
2020
Q1
$1.36M Buy
10,367
+105
+1% +$14.9K 0.2% 77
2019
Q4
$1.5M Buy
10,262
+2,703
+36% +$367K 0.17% 86
2019
Q3
$978K Sell
7,559
-520
-6% -$68.5K 0.12% 108
2019
Q2
$1.13M Sell
8,079
-13
-0.2% -$1.8K 0.14% 101
2019
Q1
$1.13M Buy
8,092
+68
+0.8% +$9.11K 0.15% 96
2018
Q4
$1.03M Sell
8,024
-8,036
-50% -$1.12M 0.15% 95
2018
Q3
$2.23M Buy
16,060
+8,019
+100% +$1.07M 0.14% 98
2018
Q2
$976K Sell
8,041
-299
-4% -$37.3K 0.13% 106
2018
Q1
$1.07M Buy
8,340
+1,409
+20% +$190K 0.14% 100
2017
Q4
$968K Buy
6,931
+190
+3% +$26.5K 0.13% 107
2017
Q3
$876K Buy
6,741
+377
+6% +$50K 0.12% 112
2017
Q2
$842K Sell
6,364
-146
-2% -$18.6K 0.13% 113
2017
Q1
$811K Sell
6,510
-1,476
-18% -$176K 0.12% 125
2016
Q4
$920K Buy
7,986
+49
+0.6% +$5.66K 0.14% 109
2016
Q3
$938K Sell
7,937
-2,676
-25% -$325K 0.14% 124
2016
Q2
$1.29M Sell
10,613
-2,225
-17% -$253K 0.2% 96
2016
Q1
$1.39M Sell
12,838
-76
-0.6% -$7.87K 0.24% 82
2015
Q4
$1.33M Buy
12,914
+213
+2% +$21.4K 0.23% 90
2015
Q3
$1.19M Sell
12,701
-2,725
-18% -$264K 0.21% 87
2015
Q2
$1.5M Buy
15,426
+2,064
+15% +$207K 0.22% 90
2015
Q1
$1.34M Buy
13,362
+6,015
+82% +$612K 0.18% 98
2014
Q4
$768K Sell
7,347
-2,222
-23% -$234K 0.1% 134
2014
Q3
$1.02M Sell
9,569
-307
-3% -$31.8K 0.14% 110
2014
Q2
$1.03M Sell
9,876
-20,919
-68% -$2.11M 0.14% 115
2014
Q1
$3.02M Buy
30,795
+961
+3% +$89.1K 0.45% 47
2013
Q4
$2.73M Buy
+29,834
New +$2.75M 0.45% 49

Other funds holding JNJ

Hollencrest Capital Management's JNJ Position: Q2 2026 in Review

Hollencrest Capital Management reduced its Johnson & Johnson (JNJ) stake by 67% in Q2 2026, selling an estimated $2.38M and leaving 4,993 shares worth $1.27M. The position accounts for 0.08% of the portfolio, ranked #136.

Hollencrest Capital Management first reported a position in JNJ in Q4 2013 and has held it in 51 quarters since. The position peaked at $3.72M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Hollencrest Capital Management held 4,993 shares of Johnson & Johnson worth $1.27M as of Q2 2026.
  • Hollencrest Capital Management sold 10,211 Johnson & Johnson shares in Q2 2026, an estimated $2.38M.
  • Johnson & Johnson made up 0.08% of Hollencrest Capital Management's portfolio in Q2 2026, its #136 holding.
  • Hollencrest Capital Management first reported a position in Johnson & Johnson in Q4 2013 and has held it in 51 quarters since.
  • Hollencrest Capital Management's Johnson & Johnson position peaked at $3.72M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.